Abbott Laboratories filed suit against Sandoz over two patents related to nicotinic acid compositions for treating hyperlipidemia. 1/30, District of Delaware, 1:2012cv00103.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.
